Prilosec Rx-to-OTC switch for heartburn to be sought by P&G and Astra Merck.
This article was originally published in The Tan Sheet
Executive Summary
PRILOSEC SWITCH TEAM P&G AND ASTRA MERCK will jointly contribute to the clinical work needed for approval of the Rx-to-OTC switch of the prescription ulcer drug omeprazole, and Procter & Gamble will handle the marketing of the OTC product once approved, the companies announced Dec. 15. Under the terms of the deal, P&G would make upfront payments to Astra Merck, plus royalties based on U.S. net sales of the OTC drug.